Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 25 Sept 2026 for Kura Oncology, Inc., €162k.
Filing timeline
BuySaleFrancis Burrows
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Francis Burrows: trading record in brief
This profile gathers the share dealings of Francis Burrows in Kura Oncology, Inc. The record holds 7 filings, for trades running from 28 January 2025 to 24 September 2026.
The open-market record consists of 5 sales worth €421k, with no purchase. Other entries cover 2 option exercises. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 25 September 2026 with an open-market sale (€197k) in Kura Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Francis Burrows
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
30,000 shares@ US$6.15Common StockSEC:0001193125-26-402815:0
20,726 shares@ US$10.8325Common StockSEC:0001193125-26-402815:1
1,311 shares@ US$8.46075.9% of flowCommon StockSEC:0001193125-26-025306:0
35,000 shares@ US$4.8095.7% of flowCommon StockSEC:0001193125-25-326948:0
846 shares@ US$7.8719100.0% of flowCommon StockSEC:0000950170-25-010117:0
5 of 5 declarations
